Boston Scientific Corporation
Boston Scientific Enters New Revolving Credit Agreement
Summary
On February 26, 2026, Boston Scientific Corporation entered into a new $3.000 billion revolving credit agreement, a $2.000 billion 364-day revolving credit agreement, and a $6.000 billion term loan credit agreement. These agreements replace a prior $2.000 billion revolving credit agreement from 2021, which was terminated on the same date. The new agreements provide various credit facilities with different terms and conditions, including interest rates, fees, and financial covenants. A copy of each agreement is attached as an exhibit to this filing.
Profitelligence Alerts
Get alerts for BSX
Be first to know when Boston Scientific Corporation files with the SEC.
Filing Categories
Advertisement
About Boston Scientific Corporation
Boston Scientific Corporation, a leading global medical device company, is renowned for developing and supplying innovative health solutions. Its primary function is to design, manufacture, and market medical devices used in interventional medical specialties such as cardiology, peripheral interventions, cardiac rhythm management, endoscopy, urology, and neuromodulation. The company's product offerings significantly impact sectors like health care, particularly those focusing on minimally invasive treatments. Boston Scientific's products help improve the quality of patient care and reduce the need for major surgery, thus playing a crucial role in modern healthcare systems. Their devices contribute to procedures that are less invasive, more effective, and often more economic, supporting better patient outcomes and quicker recovery times. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific provides its products to healthcare providers and institutions worldwide. In the financial markets, Boston Scientific Corporation holds significant influence as a major player in the healthcare industry, contributing to advancements in medical technology and shaping the future of patient care through research and development. Its presence underscores the importance of innovation in medical devices and its role in enhancing healthcare delivery.
Official SEC Documents
Advertisement